AMR Centre to partner with US biotech company

The AMR Centre at Alderley Park has signed a co-development deal with a US biotech company. The research and development facility, which specialises in antibiotics and diagnostics, has partnered with Massachusetts-based clinical-stage drug develo...

Medtech company secures investment

Manchester-based medtech company eLucid mHealth has secured investment from the GM&C Life Sciences Fund. The fund, which is based in Alderley Park, is a seed and early-stage venture capital fund targeting life sciences businesses in the Great...

Blueberry to progress Nanomedicine platform to include novel Acne therapy

Blueberry Therapeutics Ltd is pleased to announce that it has taken a significant step forward in the development of new Acne treatments by gaining support from Innovate UK to co-fund critical research of this exciting programme. Principal Scienti...

Cytox raises £2.6m led by Catapult Ventures to launch predictive test for Alzheimer’s Disease

Alderley Park, UK – 14 June 2017. Cytox, a leader in genetic testing for Alzheimer’s Disease, today announced that it has raised £2.6m to fund the commercial launch and international roll out of its novel service. The fundin...

Proveca and Tanner Pharma Initiate Global Managed Access Program for Sialanar®

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. S...

From our portfolio



viewview our portfolio

Our Team

Jonathan Lowe

view complete team

Contact us

Alderley Park
Alderley Edge
SK10 4TG

Tel: 01625 344300